JP2012050446A5 - - Google Patents

Download PDF

Info

Publication number
JP2012050446A5
JP2012050446A5 JP2011214349A JP2011214349A JP2012050446A5 JP 2012050446 A5 JP2012050446 A5 JP 2012050446A5 JP 2011214349 A JP2011214349 A JP 2011214349A JP 2011214349 A JP2011214349 A JP 2011214349A JP 2012050446 A5 JP2012050446 A5 JP 2012050446A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
protein
autoimmune
group
isoform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011214349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012050446A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012050446A publication Critical patent/JP2012050446A/ja
Publication of JP2012050446A5 publication Critical patent/JP2012050446A5/ja
Pending legal-status Critical Current

Links

JP2011214349A 2003-11-12 2011-09-29 腫瘍壊死因子αの調節のための組成物及び方法 Pending JP2012050446A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51981803P 2003-11-12 2003-11-12
US60/519,818 2003-11-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006539833A Division JP4979385B2 (ja) 2003-11-12 2004-11-12 腫瘍壊死因子αの調節のための組成物及び方法

Publications (2)

Publication Number Publication Date
JP2012050446A JP2012050446A (ja) 2012-03-15
JP2012050446A5 true JP2012050446A5 (https=) 2012-12-13

Family

ID=34590450

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006539833A Expired - Fee Related JP4979385B2 (ja) 2003-11-12 2004-11-12 腫瘍壊死因子αの調節のための組成物及び方法
JP2011214349A Pending JP2012050446A (ja) 2003-11-12 2011-09-29 腫瘍壊死因子αの調節のための組成物及び方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006539833A Expired - Fee Related JP4979385B2 (ja) 2003-11-12 2004-11-12 腫瘍壊死因子αの調節のための組成物及び方法

Country Status (12)

Country Link
US (4) US7560265B2 (https=)
EP (2) EP2357238A3 (https=)
JP (2) JP4979385B2 (https=)
CN (1) CN101018808B (https=)
AU (1) AU2004290049B2 (https=)
BR (1) BRPI0416467A (https=)
CA (1) CA2545359C (https=)
EA (1) EA012567B1 (https=)
IL (1) IL175503A0 (https=)
MX (1) MXPA06005219A (https=)
WO (1) WO2005047478A2 (https=)
ZA (1) ZA200603780B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2357238A3 (en) * 2003-11-12 2012-02-01 The Regents of The University of Colorado Compositions and methods for regulation of tumor necrosis factor-alpha
IL169622A0 (en) * 2005-07-11 2007-07-04 Yeda Res & Dev Methods of screening modulators of interleukin-32 (il-32)modulators of il-32 identified by said methods and their use
KR100855299B1 (ko) 2007-02-16 2008-08-29 건국대학교 산학협력단 인간 ｉｌ-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 ｉｌ-32측정법
US20090263377A1 (en) * 2008-04-10 2009-10-22 Charles Lin Il-32b-targeted diagnosis and therapy
JP5395725B2 (ja) * 2010-04-05 2014-01-22 富士フイルム株式会社 電子内視鏡システム
WO2012142597A1 (en) * 2011-04-15 2012-10-18 The Regents Of The University Of California A method for generating potent dendritic cells
US9273284B2 (en) 2011-04-19 2016-03-01 The Regents Of The University Of California Method for generating potent dendritic cells
CN102392043A (zh) * 2011-12-13 2012-03-28 江南大学 毕赤酵母制备人白细胞介素32β的方法
CN102660552B (zh) * 2011-12-30 2014-03-19 西北农林科技大学 一种牛白细胞介素32γ亚型的分子克隆/稳转细胞系的建立及其方法
AU2014286128B2 (en) 2013-07-03 2019-10-10 Immunoqure Ag Human anti-IL-32 antibodies
CN104975041B (zh) * 2014-12-19 2018-01-23 中山大学 一种促进单核细胞向巨噬细胞分化的方法
KR101693275B1 (ko) 2015-03-03 2017-01-05 충북대학교 산학협력단 IFN-γ 및 IL-32γ를 유효성분으로 포함하는 항암용 조성물
GB201701404D0 (en) * 2017-01-27 2017-03-15 Micropharm Ltd Therapies for treating inflammatory disorders
WO2019063884A1 (en) * 2017-09-28 2019-04-04 Turun Yliopisto INTERLEUKINE 32 AS A BIOMARKER FOR DIABETES TYPE 1
WO2025137261A1 (en) * 2023-12-20 2025-06-26 Verily Life Sciences Llc Methods of diagnosing and treating rheumatoid arthritis by identifying inflammatory initiators

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6451983B2 (en) * 1989-08-07 2002-09-17 Peptech Limited Tumor necrosis factor antibodies
NZ235148A (en) * 1989-09-05 1991-12-23 Immunex Corp Tumour necrosis factor receptor protein and dna sequences
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
GB9214857D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US6706491B1 (en) * 1999-04-09 2004-03-16 The Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by p21
AU4347701A (en) 2000-03-01 2001-09-12 Corixa Corp Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
EP1661986A1 (en) * 2000-11-17 2006-05-31 Nuvelo, Inc. Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides
US20030154032A1 (en) * 2000-12-15 2003-08-14 Pittman Debra D. Methods and compositions for diagnosing and treating rheumatoid arthritis
EP1379648A1 (en) 2001-04-18 2004-01-14 Genset S.A. Full-length human cdnas encoding potentially secreted proteins
WO2002096943A1 (en) 2001-05-25 2002-12-05 Asahi Kasei Kabushiki Kaisha Stat6-activating genes
EP1390497A2 (en) * 2001-05-25 2004-02-25 Genset Human cdnas and proteins and uses thereof
US20030092616A1 (en) * 2001-05-25 2003-05-15 Akio Matsuda STAT6 activation gene
WO2002101075A2 (en) * 2001-06-13 2002-12-19 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
US20030073623A1 (en) * 2001-07-30 2003-04-17 Drmanac Radoje T. Novel nucleic acid sequences obtained from various cDNA libraries
US20030148316A1 (en) 2001-08-01 2003-08-07 Lipford Grayson B. Methods and compositions relating to plasmacytoid dendritic cells
CA2462795A1 (en) * 2001-10-03 2003-04-10 Incyte Genomics, Inc. Secreted proteins
JP2005536186A (ja) 2002-03-07 2005-12-02 ルードビッヒ、インスティテュート、フォー、キャンサー、リサーチ リンパ管および血管内皮細胞遺伝子
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
US20050048490A1 (en) * 2002-09-26 2005-03-03 Incyte Corp. Proteins associated with cell growth, differentiation, and death
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP2357238A3 (en) * 2003-11-12 2012-02-01 The Regents of The University of Colorado Compositions and methods for regulation of tumor necrosis factor-alpha
KR100565698B1 (ko) 2004-12-29 2006-03-28 디지탈 지노믹스(주) 급성골수성백혈병(aml), b-세포형 급성임파구성백혈병(b-all), t 세포형 급성임파구성백혈병(t-all) 진단용 마커
KR100855299B1 (ko) * 2007-02-16 2008-08-29 건국대학교 산학협력단 인간 ｉｌ-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 ｉｌ-32측정법

Similar Documents

Publication Publication Date Title
JP2012050446A5 (https=)
Singh et al. The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications
Sifniotis et al. Current advancements in addressing key challenges of therapeutic antibody design, manufacture, and formulation
Ge et al. Bystander activation of pulmonary Trm cells attenuates the severity of bacterial pneumonia by enhancing neutrophil recruitment
Mohd Noor et al. Orchestrated cytokines mediated by biologics in psoriasis and its mechanisms of action
Ponce-Gallegos et al. Th17 profile in COPD exacerbations
Vanz et al. Human granulocyte colony stimulating factor (hG-CSF): cloning, overexpression, purification and characterization
Tian et al. Th22 and related cytokines in inflammatory and autoimmune diseases
JP2014077000A5 (https=)
Qiu et al. Listeria monocytogenes: a model pathogen continues to refine our knowledge of the CD8 T cell response
JP2014111644A5 (https=)
HRP20161141T1 (hr) Anti-il-23 protutijela
JP2010504361A (ja) 安定した抗体製剤およびその使用
JP2008530138A5 (https=)
JP2010500380A5 (https=)
Muth et al. Reversing the inflammatory process—25 years of tumor necrosis factor-α inhibitors
Wang et al. COVID-19: imbalanced cell-mediated immune response drives to immunopathology
JP2018521959A5 (https=)
JP2019524730A5 (https=)
Heo et al. Interplay between the gut microbiota and inflammatory mediators in the development of colorectal cancer
CA2545359A1 (en) Compositions and methods for regulation of tumor necrosis factor-alpha
Nowosielska et al. Effects of a unique combination of the whole-body low dose radiotherapy with inactivation of two immune checkpoints and/or a heat shock protein on the transplantable lung cancer in mice
EL-Baky et al. Auto-induction expression of human consensus interferon-alpha in Escherichia coli
RU2013101769A (ru) Высокоаффинные антитела человека к белку gb цитомегаловирусу (смv) человека
Jia et al. Elimination of N-glycosylation by site mutation further prolongs the half-life of IFN-α/Fc fusion proteins expressed in Pichia pastoris